MDL | MFCD00037844 |
---|---|
Molecular Weight | 413.64 |
Molecular Formula | C27H43NO2 |
SMILES | C[C@H](CC1)CN[C@]21O[C@@]3([H])C[C@@]4([H])[C@]5([H])CC=C6C[C@@H](O)CC[C@]6(C)[C@@]5([H])CC[C@]4(C)[C@@]3([H])[C@@H]2C |
Solasodine (Purapuridine) is a steroidal alkaloid that occurs in plants of the Solanaceae family. Solasodine has neuroprotective, antifungal, hypotensive, anticancer, antiatherosclerotic, antiandrogenic and anti-inflammatory activities [1] [2] .
Solasodine (90 μM; 2 days) treatment displays significant sprouting in P19 cells. Solasodine induces strong expression of the different neuronal markers studied, including βIII-tubulin, synaptophysin, MAP2, ChAT, and neuroblast marker doublecortin. Solasodine induces the differentiation of P19 cells, essentially towards the neuronal pathway [1] . Solasodine induce apoptosis by inhibiting the p53-MDM2 complex, p21 Waf1/Cip1 , and Bcl-2 proteins [3] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solasodine (25-100 mg/kg; intraperitoneal injection; once) treatment significantly delays latency of hind limb tonic extensor (HLTE) phase in the PCT-induced convulsions. And significantly potentiates Thiopental-provoked sleep in a dose-dependent manner. Solasodine has anticonvulsant and CNS depressant activities
[2]
.
Solasodine (375 μM; i.c.v.; for 2 weeks) treatment results a significant increase in bromodeoxyuridine uptake by cells of the ependymal layer, subventricular zone, and cortex that co-localized with doublecortin immunostaining. Solasodine treatment in rats results in a dramatic increase in expression of the cholesterol- and drug-binding translocator protein in ependymal cells
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: | Swiss albino mice (18-25 g) treated with Picrotoxin (PCT) or Thiopental [2] |
Dosage: | 25 mg/kg, 50 mg/kg and 100 mg/kg |
Administration: | Intraperitoneal injection; once |
Result: | Significantly delayed latency of hind limb tonic extensor (HLTE) phase in the PCT-induced convulsions. And significantly potentiated Thiopental-provoked sleep in a dose-dependent manner. |
NCT Number | Sponsor | Condition | Start Date | Phase |
---|---|---|---|---|
NCT04693000 | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |
Keratotic Nodular Size
|
September 23, 2018 | Phase 2 |
Solid
Room temperature in continental US; may vary elsewhere.
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
DMSO : 2.6 mg/mL ( 6.29 mM ; Need ultrasonic)
H 2 O : 0.67 mg/mL ( 1.62 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.4176 mL | 12.0878 mL | 24.1756 mL |
5 mM | 0.4835 mL | 2.4176 mL | 4.8351 mL |
10 mM | --- | --- | --- |